P2 Study of Postoperative Interferon/Fluorouracil vs Cisplatin/Fluorouracil for Hepatocellular Carcinoma.
Status:
Unknown status
Trial end date:
2020-02-01
Target enrollment:
Participant gender:
Summary
To evaluate the efficacy and safety of postoperative hepatic arterial infusion chemotherapy,
interferon/fluorouracil versus low-dose cisplatin/fluorouracil, in patients with
hepatocellular carcinoma with portal vein tumor thrombus.